Getting more stem cells through culture…

By /

Culture expansion of cells (growing more in culture) is critical for many successful stem cell therapy applications. 99% of the basic science research has been done with cultured cells grown to bigger numbers and not with cell concentrates (like BMAC).  The reason is simple, more stem cells (up to a critical number) are likely better than fewer.  However, we often discuss with patients that keeping cells in culture too long will likely make them less potent, so we have a “therapeutic window” where we can get more cells.  The above graph plots almost 200 knee and hip patients on reported percentage improvement in pain relief vs. the time their cells were kept in culture.  As you can see, stem cells kept for less time in culture failed to produce optimal results, just as cells kept too long produced less robust results as well (in this case the “sweet spot” was around 15-17 days).  Here is a snippet from our upcoming scientific paper on this issue:

“Pain relief vs. days in culture provides an interesting trend without statistical significance between the groups (10-14, 15-17, 18-20, 21+ days).  However, the trends are consistent with the peer reviewed literature concerning the dichotomy between the benefits of culture expansion vs. the adverse potency effects on cells of more time in culture.  For example, maximum reported therapeutic effect is seen in the 15-17 days in culture group, with less robust reports of outcome for cells cultured for les or more time.  Banfi has reported that mesencymal stem cells held for longer periods in culture lose their differentiation potential and potency.[1-2]  in addition, we would postulate that patients who had their cells harvested at earlier periods, failed to produce a critical number of cells for the therapy to have optimal success.”

1.            Banfi, A., et al., Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells. Tissue Eng, 2002. 8(6): p. 901-10.

2.            Banfi, A., et al., Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol, 2000. 28(6): p. 707-15.

Join us for a free Regenexx webinar.

If you have questions or comments about this blog post, please email us at [email protected]

NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.

Get Blog Updates by Email

By submitting the form, you are agreeing that you read and consent to our Privacy Policy. We may also contact you via email, phone, and other electronic means to communicate information about our products and services. We do not sell, or share your information to third party vendors.

Category: Regenexx-C
Copyright © Regenexx 2021. All rights reserved.

CONTACT INFORMATION

Address

9035 Wadsworth Pkwy #1000
Westminster, CO 80021

Phone

*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.

Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.

LinkedIn
Email
TO TOP